Choreo LLC’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$210K Buy
+13,136
New +$219K ﹤0.01% 1555
2025
Q4
– Sell
-10,545
Closed -$136K – 1635
2025
Q3
$136K Sell
10,545
-4,702
-31% -$62.8K ﹤0.01% 1496
2025
Q2
$271K Buy
15,247
+1,994
+15% +$34.7K ﹤0.01% 1242
2025
Q1
$236K Buy
13,253
+4,903
+59% +$111K ﹤0.01% 1229
2024
Q4
$251K Buy
+8,350
New +$177K ﹤0.01% 1282
2024
Q3
– Sell
-11,131
Closed -$192K – 1659
2024
Q2
$192K Buy
+11,131
New +$196K ﹤0.01% 1346

Other funds holding NVCR

Choreo LLC's NVCR Position: Q3 2026 in Review

Choreo LLC opened a new position in NovoCure (NVCR) in Q3 2026: 13,136 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #1555 among its holdings. This is a return to the name: Choreo LLC previously reported a position in NVCR as recently as Q3 2025.

Choreo LLC first reported a position in NVCR in Q2 2024 and has held it in 6 quarters since. The position peaked at $271K in Q2 2025. 239 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

  • Choreo LLC held 13,136 shares of NovoCure worth $210K as of Q3 2026.
  • NovoCure was a new Choreo LLC position in Q3 2026.
  • NovoCure made up ﹤0.01% of Choreo LLC's portfolio in Q3 2026, its #1555 holding.
  • Choreo LLC first reported a position in NovoCure in Q2 2024 and has held it in 6 quarters since.
  • Choreo LLC's NovoCure position peaked at $271K in Q2 2025.
  • 239 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on Choreo LLC's 13F filing for Q3 2026, filed 28 Oct 2026.